Synaptics (NASDAQ:SYNA) Stock Rating Cut to Hold at Wells Fargo & Company
Synaptics (NASDAQ:SYNA – Get Free Report) was downgraded by Wells Fargo & Company from a “strong-buy” rating to a “hold” rating in a research report issued on Friday, Zacks reports. Other analysts have also recently issued research reports about the stock. Rosenblatt Securities boosted their target price on shares of Synaptics from $115.00 to $123.00 […]
Interactive Brokers Group (NASDAQ:IBKR) Upgraded to “Strong-Buy” at Wells Fargo & Company
Interactive Brokers Group (NASDAQ:IBKR – Get Free Report) was upgraded by analysts at Wells Fargo & Company to a “strong-buy” rating in a research note issued on Friday, Zacks reports. Several other research analysts also recently weighed in on IBKR. Wolfe Research assumed coverage on Interactive Brokers Group in a research note on Monday, June […]
Design Therapeutics (NASDAQ:DSGN) Stock Rating Upgraded by Wells Fargo & Company
Design Therapeutics (NASDAQ:DSGN – Get Free Report) was upgraded by Wells Fargo & Company to a “strong-buy” rating in a report issued on Friday, Zacks reports. Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Design Therapeutics in a report on Friday, July 17th. Two analysts have rated the stock with a Strong […]
Beta Bionics (NASDAQ:BBNX) Upgraded by Wells Fargo & Company to “Strong-Buy” Rating
Wells Fargo & Company upgraded shares of Beta Bionics (NASDAQ:BBNX – Free Report) to a strong-buy rating in a research note published on Wednesday morning,Zacks reports. BBNX has been the topic of several other research reports. Truist Financial reissued a “buy” rating and set a $23.00 target price (up from $22.00) on shares of Beta […]
last updated on 3 Oct 11:54